Austria vs Bulgaria: The number of people with susceptibility test result for rifampicin
Austria
165
in 2021
Bulgaria
156
in 2021
Austria rank
98th
Bulgaria rank
100th
The number of people with susceptibility test result for rifampicin over time
- Austria
- Bulgaria
How they compare
Austria currently reports 165 against 156 in Bulgaria, a difference of 9.
That makes Austria's figure about 1.1 times Bulgaria's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Bulgaria ahead.
Austria ranks 98th and Bulgaria ranks 100th of 155 countries.
Bulgaria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Austria | Bulgaria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 220.67 | 467.67 | 247 | Bulgaria |
| 2020s | 169 | 181.5 | 12.5 | Bulgaria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Austria or Bulgaria?
- Austria, at 165 against 156 in Bulgaria as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Austria and Bulgaria?
- 9, with Austria ahead.
- How many years of comparable data are there for Austria and Bulgaria?
- 5 years are reported by both, from 2017 to 2021.
- How do Austria and Bulgaria rank globally for the number of people with susceptibility test result for rifampicin?
- Austria ranks 98th and Bulgaria ranks 100th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.